{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:04:05Z","timestamp":1789603445644,"version":"build-2803163510"},"reference-count":96,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["IF\/R2\/222031"],"award-info":[{"award-number":["IF\/R2\/222031"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1080\/17425247.2024.2396958","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T15:57:35Z","timestamp":1724428655000},"page":"1311-1329","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Potential bladder cancer therapeutic delivery systems: a recent update"],"prefix":"10.1080","volume":"21","author":[{"given":"Oluwadamilola M.","family":"Kolawole","sequence":"first","affiliation":[{"name":"University of Lagos","place":["Lagos, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-2630","authenticated-orcid":false,"given":"Vitaliy V.","family":"Khutoryanskiy","sequence":"additional","affiliation":[{"name":"University of Reading","place":["Berkshire, Reading, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.08.120"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.10.024"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000078"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09993.x"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.01.086"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(00)00350-2"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2008.08.002"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S56168"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S140111"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2010.08.031"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2017.1312441"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.778973"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091909"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092214"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01104-y"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.879828"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10353"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.14.212"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010211"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00313-1"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133181"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672262"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2024.2307481"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102218"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020559"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2007.03.017"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b18717"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1039\/C4RA13581D"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.09.039"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218019"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.8b04256"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120051"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.03.006"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-5-49"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.11.009"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S103994"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23243"},{"key":"e_1_3_4_40_1","unstructured":"DrugBank. Belinostat: uses interactions mechanisms of action. [cited 2021 Dec 24]. Available from: https\/\/www:go.drugbank.com\/drugs\/DB05015"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2013.05.017"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01752-7"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5TB00834D"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcn.2001.117539"},{"issue":"5","key":"e_1_3_4_45_1","first-page":"323\u20136, 331","article-title":"Bladder cancer: current optimal intravesical treatment","volume":"25","author":"Lamm D","year":"2005","unstructured":"Lamm D, McGee W, Hale K. Bladder cancer: current optimal intravesical treatment. Urol Nurs. 2005;25(5):323\u20136, 331\u20132.","journal-title":"Urol Nurs"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2019.08.007"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102481"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.2c00558"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/02652048.2012.668957"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040870"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2756-5"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1941-9635.2015.tb01419.x"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12080751"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1039\/c4nr07245f"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2017.1309475"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/la500746e"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124957"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2014.867326"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2023.01.007"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2019.100007"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S93750"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2SC02074B"},{"key":"e_1_3_4_63_1","unstructured":"FDA. Topical drug products containing Papain: enforcement action dates: FDA. [cited 2023 Jun 20]. Available from: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2008-09-23\/pdf\/E8-22300.pdf"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23854"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1039\/c2nr31592k"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S216432"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01575-7"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01515-5"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.2c00228"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.1c00741"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121513"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c08108"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.012070"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.06.084"},{"key":"e_1_3_4_75_1","unstructured":"ClinicalTrialsgov. Safety and tolerability of GemRIS 225 mg in subjects with muscle-invasive bladder cancer. U.S. National Library of Medicine. [cited 2023 Dec 20]. Available from: https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2016-00507"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.02.009"},{"key":"e_1_3_4_77_1","unstructured":"ClinicalTrialsgov. Proliposomal intravesical paclitaxel for treatment of low-grade stage Ta non-muscle-invasive bladder cancer. U. S. National Library of Medicine. [cited 2023 Dec 20]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03081858"},{"key":"e_1_3_4_78_1","unstructured":"Rosa K(Onclive). Lipax elicits encouraging RFS rate in non-muscle invasive bladder cancer. [cited 2023 Dec 20].Available from: https:\/\/www.onclive.com\/view\/lipax-elicits-encouraging-rfs-rate-in-non-muscle-invasive-bladder-cancer"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002186"},{"key":"e_1_3_4_80_1","unstructured":"ClinicalTrialsgov. A phase 2b study of UGN-102 for low grade intermediate risk non-muscle-invasive bladder cancer (OPTIMA II). U.S. National Library of Medicine. [cited 2023 Dec 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03558503"},{"key":"e_1_3_4_81_1","volume-title":"A phase 3 study of UGN-102 for low grade intermediate risk non-muscle invasive bladder cancer (ATLAS)","author":"ClinicalTrialsgov","year":"2024","unstructured":"ClinicalTrialsgov. A phase 3 study of UGN-102 for low grade intermediate risk non-muscle invasive bladder cancer (ATLAS). Princeton (NJ): U.S. National Library of Medicine; 2024."},{"key":"e_1_3_4_82_1","unstructured":"Sava J. UGN-102 meets primary end-points in phase 3 trials of LG-IR-NMIBC. Targeted oncology. [cited 2023 Dec 20]. Available from: https:\/\/www.targetedonc.com\/view\/ugn-102-meets-primary-end-points-in-phase-3-trials-of-lg-ir-nmibc"},{"key":"e_1_3_4_83_1","unstructured":"ClinicalTrialsgov. A phase 3 study of UGN-102 for low grade intermediate risk non-muscle invasive bladder cancer (ATLAS). U.S. National Library of Medicine. [cited 2023 Dec 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04688931"},{"key":"e_1_3_4_84_1","unstructured":"Clinicaltrialsgov. A phase I intravesical PPM therapy for NMIBC. US National Library of Medicine. [cited 2023 Dec 20]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05519241"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060784"},{"key":"e_1_3_4_86_1","unstructured":"Taylor P. FDA approved drug product for low-grade bladder cancer. [cited 2022 Mar 4]. Available from: https:\/\/www.pmlive.com\/pharma_news\/urogen_wins_first_fda_approval_for_low-grade_bladder_cancer_drug_1338496"},{"key":"e_1_3_4_87_1","unstructured":"FDA. FDA approval of generic version of cancer drug Doxil is expected to help resolve shortage Oncology times. [cited 2023 Dec 20]. Available from: https:\/\/www.fiercepharma.com\/pharma\/fda-approval-of-generic-version-of-cancer-drug-doxil-expected-to-help-resolve-shortage"},{"key":"e_1_3_4_88_1","unstructured":"Medscape. Doxil Lipodox (doxorubicin liposomal). 2023 [cited 2023 Jun 10]. Available from: https:\/\/reference.medscape.com\/drug\/doxorubicin-liposomal-342121"},{"key":"e_1_3_4_89_1","unstructured":"IndiaMart. \u201cBevetex 100 mg injection (paclitaxel). [cited 2023 Dec 20].Available from: https:\/\/www.indiamart.com\/proddetail\/bevetex-100-mg-injection-paclitaxel-27144627273.html"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.05.016"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.2.3.345"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-1958-5"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2012.09.037"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm7040012"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.03.010"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2007.223"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175024"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137311"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2024.2396958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T12:11:22Z","timestamp":1746619882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2024.2396958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1080\/17425247.2024.2396958"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2024.2396958","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}